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A multistep continuous flow synthesis machine for
the preparation of pyrazoles via a metal-free
amine-redox process†‡
Jian-Siang Poh,a Duncan L. Browne*ab and Steven V. Leya
A versatile multistep continuous flow setup is reported for the four-step conversion of anilines into
pyrazole products. The synthesis machine incorporates the use of amine-redox chemistry through diazoti-
zation and a metal-free vitamin C mediated reduction. The machine can be used for the synthesis of an ar-
ray of analogues or the scale up of an individual target.
Introduction
The synthesis of heterocyclic compounds continues to serve
as a cornerstone for the preparation of materials necessary
for our modern society. The way in which such materials are
constructed is therefore an important area of research
whereby ease of diversity, simplicity of scale up and sustain-
ability of the method represent key factors in the future ad-
vancement of this established field. In the case of pyrazoles,
five-membered heterocycles featuring two adjacent nitrogen
atoms, their functionality is characterized by their appearance
in materials, agrochemicals and pharmaceuticals, examples
of which are celecoxib (1), crizotinib, sildenafil and
pyrazoxyfen (Fig. 1a).1 At scale these compounds are most
commonly prepared by the cyclo-condensation of hydrazines
with 1,3-dicarbonyl compounds or their equivalents. This can
be achieved by either the cyclo-condensation with simple hy-
drazine followed by a non-selective alkylation of a tautomeric
mixture, or by appropriate substitution of hydrazine followed
by an electronically controlled regioselective cyclo-
condensation (Fig. 1b). The latter approach is often preferred
as it leads to more selective processes. However, both strate-
gies require the preparation and storage of hydrazines on
scale, a practice which represents a significant safety risk,
economic investment and is applicable to a relatively limited
substrate scope.
Substituted hydrazines are often prepared by nucleophilic
aromatic substitution (SNAr) of the appropriately activated
benzene systems, or more recently, utilising palladium-
catalysed cross-coupling methods with hydrazine. In the lat-
ter case, the scope has been increased by the development of
important ligands that permit a difficult reductive elimina-
tion step.2 Although this cross-coupling approach may have
some way to go before its application on scale becomes eco-
nomically and environmentally sustainable, some headway
has been made with the development of a continuous flow
approach.3 An alternative option, which permits access to a
vast range of substituted hydrazines centres on the use of
amine-redox chemistry. This method consists of oxidation
through diazotization, followed by reduction of the N–N tri-
ple bond, commonly with tinĲII) chloride (Fig. 1b).4
However, in recent years there has been an interest in
moving towards more sustainable reductants, those that can
be washed away from the product through simple aqueous
extraction where ascorbic acid or sodium sulfite serve as re-
ductant, including our own previous mechanistic work and
flow proof-of-concept.5 Here we describe the first report of an
end-to-end multistep6 continuous flow process7 for the
amine-redox cycle followed by hydrolysis of the hydrazine
surrogate and ensuing cyclo-condensation, a process
characterised by low inventories of both diazonium salt and
hydrazine at any one time and the use of vitamin C as
reductant.8
Results and discussion
Our first experiments towards this goal commenced with the
development of compatible flow conditions for the reduction
stage followed by hydrolysis and cyclo-condensation (Fig. 2).
Aiming for N-arylated pyrazoles, we tested the performance of
the setup by injecting 0.8 mmol segments of
4-trifluoromethylbenzenediazonium tetrafluoroborate (2, 0.2
M in MeCN) and L-ascorbic acid (3, 0.2 M in H2O) which were
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combined at a T-piece and passed through a preliminary re-
actor coil where the reduction stage could take place. This so-
lution then passed through an in-line flow IR device which
served two purposes: (i) to monitor the presence of the de-
sired carbonyl stretching frequency resulting from the oxa-
mate moiety as well as to monitor levels of diazonium com-
pound still on-stream; (ii) to actively control the flow rate of a
third pump9 delivering both pentane-2,4-dione and the
hydrochloric acid necessary for oxamate cleavage so that stoi-
chiometries could be matched with the flowing segment,
thus delivering matched concentration profiles.
Once combined with the acid and the dione, the stream
then passed through a heated coil before emerging at the
output through a 100 psi back-pressure regulator. The flow
procedure developed here offers advantages over batch proce-
dures, allowing rapid screening of reaction conditions with
minimal operator input, as well as the in situ formation of
unstable and/or explosive intermediates (hydrazides and hy-
drazines) to minimize operator exposure.
With an appropriate apparatus setup to optimize the
three-step reduction/hydrolysis/cyclo-condensation sequence
established, various parameters were investigated (Table 1).
Notably, it was found that the final yield of pyrazole was
highly dependent on the residence time for the reduction
step with tR = 6 min appearing to be optimal; a decreased res-
idence time does not allow the reduction to proceed to com-
pletion, whereas increased residence times result in greater
decomposition of hydrazide 4. We are mindful here of recent
reports on the catalytic generation of radical intermediates
through the action of ascorbic acid on diazonium salts as a
likely competing pathway.10 There is also an optimum tem-
perature for reactor coil 2 around 140 °C, where higher than
this seemed to result in reduced yields of pyrazole products.
Optimal conditions were found (Table 1, entry 4), providing
pyrazole 5 in 69% yield after isolation.
Next we sought to assess the scope of the reaction, but
with the following modifications to the flow procedure: (i) it
would be preferable for the diazonium salts to also be pro-
duced in situ from their corresponding anilines, thus
avoiding the isolation and handling of additional explosive
species; (ii) a transformation of the procedure from seg-
mented flow to continuous flow would allow safe scale-up to
provide gram-quantities of N-arylated pyrazoles. A ‘diazotiza-
tion module’ was easily incorporated into the existing flow
set-up to replace the diazonium tetrafluoroborate input
stream, resulting in a four-step telescoped flow procedure
(Fig. 3a).
In order to assess whether the new flow set-up with the in
situ generation of diazonium chloride salts (as opposed to
the tetrafluoroborate salts) was compatible with the existing
reduction, hydrolysis and condensation steps, we subjected
4-trifluoromethylaniline to the fully telescoped process, un-
dergoing diazotization with 1 equiv. of t-butyl nitrite, reduc-
tion with 1 equiv. of L-ascorbic acid and condensation with
1.1 equiv. of pentane-2,4-dione, run under continuous flow
conditions for 2 h. Pleasingly, the desired pyrazole 5 was iso-
lated in 69% yield over four steps, in good agreement with
the previously optimized results. Scope of the reaction and
flow process with respect to anilines was then explored. In
general, most electron-withdrawing substituents on the ani-
lines were tolerated (Fig. 3b). Notably, anthranilic acid, whose
diazonium derivative is known to decompose (explosively, if
uncontrolled) to benzyne could be effectively employed in the
flow process and provided pyrazole 7 in 61% yield.
Fig. 1 a Examples of pyrazole scaffolds. b Synthetic approaches
towards pyrazole scaffolds.
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Conversion of the 4-pentafluorosulfanyl amine to pyrazole 12
via its corresponding, previously unknown, hydrazine
proceeded in a moderate 45% yield. Electron-rich systems
such as 4-methoxyaniline were not tolerated in the reduction
step, but heteroaromatic ring systems were applicable; both
3-amino-2-chloropyridine and 3-aminoquinoline provided the
desired pyrazoles (11 and 13) in good yields.
Next, a variety of 1,3-dicarbonyl compounds or equivalents
were examined in the telescoped multistep process (Fig. 3c).
The unsymmetrical 1,3,4-tricarbonyl compound 14 provided
pyrazoles 15 (ref. 11) and 16 as single regioisomers, in a com-
bined yield of 78%. Acetylenic ketone 17 and
3-aminocrotononitrile (19) were also converted to pyrazole 18
and 20 (ref. 11) respectively as single regioisomers within the
standard operating conditions of this pyrazole synthesising
machine. Enaminone 21 was also an effective substrate lead-
ing to 57% yield of a 3 : 1 mixture of pyrazole regioisomers
(22a and 22b).
As a further illustration of the utility of the telescoped pro-
cedure, perhaps as a machine to aid possible drug discovery,
a selection of relevant 1,3-diketones were crossed with aniline
starting materials to yield pyrazole analogues of celecoxib (1)
as a product output (Fig. 3d). Furan-bearing, penta-
fluorosulfanyl pyrazole 23 was furnished in 46% yield,
whereas the N-pyridyl variant (24) was isolated in 48% yield.
A scale-up experiment where the machine was running for a
12 hour period demonstrated the synthesis of the
4-nitrophenyl analogue 25 in 40% yield, affording 3.76 g of
the isolated pyrazole product. Finally, the appropriate sulfa-
nilamide was diazotized, reduced with L-ascorbic acid, hydro-
lyzed and condensed with the corresponding dione to provide
the COX-2 selective non-steroidal anti-inflammatory drug
celecoxib (1) in 48% yield over four continuous steps.
Conclusions
In summary, we have reported a metal-free continuous flow
method for the generation of a variety of N-arylated pyrazoles
via amine-redox chemistry. The telescoped flow process of-
fers a distinct advantage over corresponding batch proce-
dures due to the in situ formation and use of several reactive
intermediates. Critically, this end-to-end style of synthesis
avoids the stock-piling and storage of hazardous drug inter-
mediates (diazonium salts and hydrazines) by advancing
them to the next step as they are produced. The machine,
and conditions/parameters reported here are applicable to a
relatively broad range of amine and 1,3-dicarbonyl materials.
Further investigations into the handling and use of reactive
intermediates in flow as well as the development of multistep
machines to support the synthesis and discovery process are
currently ongoing in our laboratories.
Fig. 2 Equipment setup for segmented flow reduction/hydrolysis/cyclo-condensation sequence.
Table 1 Optimization of conditions for segmented flow reduction/hy-
drolysis/cyclo-condensation sequence
Entry Coil 1, tR/min Coil 2, T/°C Equiv. of HCl Yield
a (%)
1 2.5 100 5.5 21
2 2.5 140 5.5 46
3b 2.5 140 5.5 45
4 6 140 5.5 71 (69)
5 10 140 5.5 67
6 18 140 5.5 62
7 35 140 5.5 58
8 6 100 5.5 21
9 6 120 5.5 55
10 6 160 5.5 53
11c 6 140 5.5 70
12d 6 140 5.5 71
13 6 140 0 35
14 6 140 2.2 68
15 6 140 11 58
All entries run on 0.8 mmol scale with respect to diazonium
tetrafluoroborate, with r.t. in coil 1 and a 35 minute residence time
in reactor coil 2, 1.1 equivalents of dione and 1 equivalent of
ascorbic acid.a Yield determined from quantitative 1H NMR analysis
with DMF as internal standard, yield of isolated product in
parentheses. b 63 minute residence time in reactor coil 2. c 2.2
equivalents of dione used. d 2 equivalents of ascorbic acid used.
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Fig. 3 Equipment setup and scope for the continuous flow diazotization/reduction/hydrolysis/cyclo-condensation sequence. a Entries run on 4.8
mmol scale with respect to aniline unless otherwise stated, yields represent isolated product. b Using NaNO2 in H2O as diazotizing agent.
c Using a
15 mL reaction coil at 30 °C for the reduction module. d Run on 28.8 mmol scale over 12 hours.
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